Loading organizations...
Ironic Biotech, based in Lund, Sweden, develops plant-derived proteins containing highly bioavailable iron through precision fermentation, aiming to combat global iron deficiency. These proteins are designed to mimic meat's iron absorption without common side effects or metallic taste, serving as ingredients for food fortification, food supplements, nutraceuticals, functional beverages, and medical nutrition. The company's technology addresses the challenge of iron deficiency, which affects an estimated 2 billion people worldwide. Ironic Biotech has secured €1 million in pre-seed funding, with Nordic Foodtech VC as a lead investor, and currently operates with a team of 5 employees. Key individuals involved include founder and CEO Nélida Leiva Eriksson, Eskil Åhlin, and Hans Holm. The organization was founded in 2020 by Nélida Leiva Eriksson.
Ironic Biotech has raised $1.1M across 1 funding round.
Ironic Biotech has raised $1.1M in total across 1 funding round.
Ironic Biotech has raised $1.1M in total across 1 funding round.
Ironic Biotech has raised $1.1M across 1 funding round. Most recently, it raised $1.1M Pre-Seed in April 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 4, 2024 | $1.1M Pre Seed | — | — | Announced |